What is NDC 86211-116?

86211-116 is the product NDC for Doxycycline, Doxycycline hyclate 100 mg/10mL injection, powder, lyophilized, for solution, listed with the FDA by JVET PHARMACEUTICALS LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

JVET PHARMACEUTICALS LLC, NDC labeler code 86211. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Doxycycline?

136 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Doxycycline NDC 86211-116 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)86211-116Labeler and product segments. Claims need a package NDC.

Product NDC at billing width86211-0116Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
86211-116-10	8621101161086211011610	10 VIAL in 1 CARTON (86211-116-10) / 10 mL in 1 VIALMarketed from Jan 27, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxycycline
Generic name (nonproprietary): doxycycline
Active ingredients: Doxycycline hyclate — 100 mg/10mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: JVET PHARMACEUTICALS LLCNDC labeler code 86211
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215583
Marketing start: Jan 27, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Tetracyclines (Chemical structure)
Identifiers: Product ID 86211-116_ed95709e-2a1a-4deb-88bd-5b99f02b7a26SPL ID ed95709e-2a1a-4deb-88bd-5b99f02b7a26SPL set ID ed95709e-2a1a-4deb-88bd-5b99f02b7a26RxCUI 310027UNII 19XTS3T51U
Pharmacologic class: Tetracycline-class Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N486211011610 followed by a unit qualifier and the quantity

Package 86211-0116-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 27, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of Doxycycline for Injection, USP and other antibacterial drugs, Doxycycline for Injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Doxycycline for Injection, USP is indicated in infections caused by the following microorganisms: • Rickettsi…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 86211-116

What is NDC 86211-116?: 86211-116 is the product NDC for Doxycycline, Doxycycline hyclate 100 mg/10mL injection, powder, lyophilized, for solution, listed with the FDA by JVET PHARMACEUTICALS LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Doxycycline.
What is the active ingredient?: Doxycycline hyclate.
Who is the labeler?: JVET PHARMACEUTICALS LLC, NDC labeler code 86211. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Doxycycline?: 136 other product NDCs are listed under this name. See all Doxycycline NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Doxycycline NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Doxycycline	Doxycycline 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4762	70518-4762-00
doxycycline	Doxycycline 50 mg/1	CapsuleOral	Safecor Health, LLC	48433-158	48433-0158-03
doxycycline	Doxycycline 100 mg/1	CapsuleOral	Safecor Health, LLC	48433-159	48433-0159-03
doxycycline	Doxycycline 100 mg/1	CapsuleOral	Coupler LLC	67046-1260	67046-1260-03
doxycycline	Doxycycline hyclate 100 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-4176	68788-4176-0068788-4176-0168788-4176-02+3 more
doxycycline	Doxycycline hyclate 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4655	70518-4655-0070518-4655-01
Doxycycline	Doxycycline hyclate 100 mg/100mg	Injection, Powder, Lyophilized, For solutionIntravenous	Steriscience Specialties Private Limited	82449-008	82449-0008-02
Doxycycline	Doxycycline 100 mg/1	CapsuleOral	American Health Packaging	60687-943	60687-0943-21
Doxycycline	Doxycycline 40 mg/1	CapsuleOral	AiPing Pharmaceutical, Inc.	11788-134	11788-0134-30
Doxycycline	Doxycycline 40 mg/1	CapsuleOral	Solco Healthcare US,LLC	43547-590	43547-0590-03

All 137 Doxycycline NDCs

Other NDCs under ANDA 215583

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215583
Product	Strength	Form · route	Labeler	Product NDC
Doxycycline	Doxycycline hyclate 100 mg/10mL	Injection, Powder, Lyophilized, For solutionIntravenous	Piramal Critical Care Inc	66794-237
Doxycycline	Doxycycline hyclate 100 mg/10mL	Injection, Powder, Lyophilized, For solutionIntravenous	Gland Pharma Limited	68083-481
Doxycycline	Doxycycline hyclate 100 mg/10mL	Injection, Powder, Lyophilized, For solutionIntravenous	FOSUN PHARMA USA INC	72266-237